IDH1 and oligodendroglioma: In other words, while the presence of IDH mutation is required for the molecular diagnosis of an astrocytoma or oligodendroglioma, in tumours such as ganglioglioma, pleomorphic xanthoastrocytoma or pilocytic astrocytoma the BRAF V600E mutation is not always present.